Werewolf Therapeutics, Inc. - Common Stock (NQ:HOWL)

0.9350 -0.0250 (-2.60%)

Streaming Delayed Price Updated: 3:03 PM EDT, Sep 28, 2026 Add to My Watchlist

Price and Volume

Volume	606,064
Open	0.9700
Bid (Size)	0.9300 (33,100)
Ask (Size)	0.9400 (200)
Prev. Close	0.9600
Today's Range	0.9250 - 0.9700
52wk Range	0.2700 - 2.380
Shares Outstanding	27,567,728
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, LNTH are Obtaining Fair Deals for their Shareholders

September 24, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

September 24, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Performance

YTD	+45.0%	+45.0%
1 Month	-0.9%	-0.9%
3 Month	+203.6%	+203.6%
6 Month	+17.3%	+17.3%
1 Year	-57.3%	-57.3%

More News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

September 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Werewolf Therapeutics (NASDAQ:HOWL) Meets Q1 Estimates, Clears Debt, and Advances Strategic Review ↗

May 07, 2026

Via Chartmill

September 03, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, CBZ are Obtaining Fair Deals for their Shareholders

August 24, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ)

August 24, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

August 23, 2026

From Halper Sadeh LLC

Via Business Wire

Friday's session: top gainers and losers ↗

August 21, 2026

Via Chartmill

Friday's session: most active stocks ↗

August 21, 2026

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 21, 2026

Via Benzinga

The trading volume of these stocks is deviating from the norm in today's session. ↗

August 21, 2026

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

August 21, 2026

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

August 21, 2026

Via Chartmill

Which stocks are moving before the opening bell on Friday? ↗

August 21, 2026

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 21, 2026

Via Benzinga

Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement

August 21, 2026

From Ambros Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 20, 2026

Via Benzinga

These stocks are moving in today's after hours session ↗

August 20, 2026

Via Chartmill

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

July 31, 2026

From Werewolf Therapeutics, Inc.

Via GlobeNewswire

These stocks are moving in today's after hours session ↗

May 15, 2026

Via Chartmill

Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates

May 07, 2026

From Werewolf Therapeutics, Inc.

Via GlobeNewswire

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

March 27, 2026

From Werewolf Therapeutics, Inc.

Via GlobeNewswire

Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives

February 24, 2026

From Werewolf Therapeutics, Inc.

Via GlobeNewswire

Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives ↗

February 13, 2026

Via Stocktwits

Frequently Asked Questions

Is Werewolf Therapeutics, Inc. - Common Stock publicly traded?

Yes, Werewolf Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Werewolf Therapeutics, Inc. - Common Stock trade on?

Werewolf Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Werewolf Therapeutics, Inc. - Common Stock?

The ticker symbol for Werewolf Therapeutics, Inc. - Common Stock is HOWL on the Nasdaq Stock Market

What is the current price of Werewolf Therapeutics, Inc. - Common Stock?

The current price of Werewolf Therapeutics, Inc. - Common Stock is 0.9350

When was Werewolf Therapeutics, Inc. - Common Stock last traded?

The last trade of Werewolf Therapeutics, Inc. - Common Stock was at 09/28/26 03:03 PM ET

What is the market capitalization of Werewolf Therapeutics, Inc. - Common Stock?

The market capitalization of Werewolf Therapeutics, Inc. - Common Stock is 25.78M

How many shares of Werewolf Therapeutics, Inc. - Common Stock are outstanding?

Werewolf Therapeutics, Inc. - Common Stock has 26M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.